These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2219368)

  • 1. Cyclosporine: its time of impact on kidney graft survival.
    Gilks WR; Bradley BA; Gore SM
    Transplant Proc; 1990 Oct; 22(5):2282. PubMed ID: 2219368
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
    Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of cyclosporine A in cadaver donor retransplants: a surprising effect of the sex of the donor.
    Cecka JM; Cicciarelli J; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1842-4. PubMed ID: 3274440
    [No Abstract]   [Full Text] [Related]  

  • 4. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
    Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of cyclosporine A on the DRw6 effect in renal transplantation.
    Hendriks GF; de Lange P; Schreuder GM; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):650-1. PubMed ID: 3274832
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing kidney graft survival in the cyclosporine era: a multivariate analysis.
    Tiwari J; Terasaki PI; Mickey MR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1839-41. PubMed ID: 3274439
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal allograft survival in highly sensitized patients treated with cyclosporine.
    Doran M; Coppage M; Ruth J; Fish J; Winsett O; Vaidya S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1988. PubMed ID: 3274458
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF; de Lange P; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of HLA matching on kidney allograft survival.
    Suciu-Foca N; Cohen DJ; Benvenisty AI; Benstein JA; Reed EF; Ho E; Hardy MA
    Transplant Proc; 1996 Feb; 28(1):121-2. PubMed ID: 8644140
    [No Abstract]   [Full Text] [Related]  

  • 11. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 12. Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years.
    Alexander JW; Vaughn WK; Pfaff WW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):672-4. PubMed ID: 3274836
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of peritransplant variables on short- and predicted long-term outcome in cyclosporine-treated recipients of cadaveric renal allografts.
    Lindholm A; Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Persson N; Groth CG
    Transplant Proc; 1990 Aug; 22(4):1429-30. PubMed ID: 2202118
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
    Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid withdrawal in HLA-nonidentical living-related donor transplant recipients.
    Mendez R; Aswad S; Mendez RG; Cicciarelli J; Asai P; Sakhrani L; Bogaard T; Khetan U; Flores N
    Transplant Proc; 1992 Oct; 24(5):1891-3. PubMed ID: 1412901
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
    Persijn GG; D'Amaro J; De Lange P; Schreuder GM; Thorogood J; Zantvoort F; Van Rood JJ
    Clin Transpl; 1988; ():237-48. PubMed ID: 3154476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine and kidney graft survival: a review.
    Tiwari JL
    Clin Transpl; 1986; ():345-66. PubMed ID: 3154432
    [No Abstract]   [Full Text] [Related]  

  • 20. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.